Предыдущая страница Следующая страница Главная страница сайта Написать письмо
Навигация

Смоленская государственная медицинская академия


НЕЖЕЛАТЕЛЬНЫЕ ЛЕКАРСТВЕННЫЕ РЕАКЦИИ И ВЗАИМОДЕЙСТВИЯ
ПРИ АНТИБИОТИКОТЕРАПИИ ИНФЕКЦИЙ МОЧЕВЫВОДЯЩИХ ПУТЕЙ

методическое пособие

Содержание НР и лекарственные взаимодействия антибиотиков, наиболее часто применяемых для лечения ИМП
Резюме

Сокращения

Литература		 b-лактамы: Аминогликозиды
Ко-тримоксазол
Нефторированные хинолоны:
    налидиксовая, оксолиниевая, пипемидовая кислота
 Фторхинолоны		 Нитрофураны:
Фосфомицина трометамол
Хинолины

Литература

  1. White T.J. Counting the Cost of Drug-Related Adverse Events. Pharmacoeconomics 1999; 15: 445-458.
  2. Lazarou J., Pomeranz B., Corey P. Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies. JAMA 1998; 279: 1200-1205.
  3. Garcia Rodriguez L.A., Stricker B.H., Zimmerman H.J. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med 1996; 156: 1327-1332.
  4. Limauro D.L., Chan-Tompkins N.H., Carter R.W. e.a. Amoxicillin/clavulanate-associated hepatic failure with progression to Stevens-Johnson syndrome. Ann Pharmacother 1999; 33: 560-564.
  5. Neu H.C., Wilson A.P.R., Gruneberg R.N. Amoxycillin/Clavulanic Acid: a Review of its Efficacy in over 38,500 Patients from 1979 to 1992. J Chemother 1993; 5: 67-93.
  6. Thompson J.W., Jacobs R.F. Adverse effects of newer cephalosporins. An update. Drug Saf 1993; 9: 132-142.
  7. Norrby S.R. Side Effects of Cephalosporins. Drugs 1995; 34 (Suppl. 2): 105-120.
  8. Karchmer A.W. In: Principles and Practice of Infectious Diseases / Ed. by G. L. Mandel, J.E. Bennett, R. Dolin.- 5th ed.- Philadelphia, 2000.- P. 275-291.
  9. Hoitsma A.J., Wetzels J.F., Koene R.A. Drug-induced nephrotoxicity. Aetiology, clinical features and management. Drug Saf 1991; 6: 131-147.
  10. McCarty J.M., Richard G., Huck W. e.a. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Am J Med 1999; 106: 292-299.
  11. Naldi L., Conforti A., Venegoni M. et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48: 839-846.
  12. Mockenhaupt M., Schopf E. / Progress in Allergy and Clinical Immunology, vol. 4, Cancun (Mexico): proceedings of the XVIth International Congress of Allergology and Clinical Immunology, Cancun, Mexico, 1997.- P. 352-360.
  13. Mahboob A., Haroon T.S. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol 1998; 37: 833-838.
  14. van der Klauw M.M., Wilson J.H., Stricker B.H. Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974-1994) and review of the literature. Clin Exp Allergy 1996; 26: 1355-1363.
  15. Pedersen-Bjergaard U., Andersen M., Hansen P.B. . Thrombocytopenia induced by noncytotoxic drugs in Denmark 1968-91. J Intern Med 1996; 239: 509-515.
  16. Miyagawa S., Yamashina Y., Hirota S., Shirai T. . Fixed drug eruption due to pipemidic acid. J Dermatol 1991; 18: 59-60.
  17. Ball P., Tillotson G. Tolerability of fluoroquinolone antibiotics. Past, present and future. Drug Saf 1995; 13: 343-358.
  18. Harrell R.M. Fluoroquinolone-Induced Tendinopathy: What Do We Know? South Med J 1999; 92: 622-625.
  19. Lipsky B.A., Baker C.A. Fluoroquinolone Toxicity Profiles: A Review Focusing on Newer Agents. Clin Infect Dis 1999; 28: 352-364.
  20. Henry D.C., Nenad R.C., Iravani A. et al. . Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group. Clin Ther 1999; 21: 966-981.
  21. Scrip.- 1996.- N. 2153.- P.16.
  22. Kashida Y., Kato M. Characterization of fluoroquinolone-induced Achilles tendon toxicity in rats: comparison of toxicities of 10 fluoroquinolones and effects of anti-inflammatory compounds. Antimicrob Agents Chemother 1997; 41: 2389-2393.
  23. Bottiger L.E., Westerholm B. Adverse drug reactions during treatment of urinary tract infections. Eur J Clin Pharmacol 1977; 11: 439-442.
  24. Hallas J., Gram L.F., Grodum E., Damsbo N., Brosen K., Haghfelt T. et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33: 61-68.
  25. Jick S.S., Jick H., Walker A.M., Hunter J.R. Hospitalizations for pulmonary reactions following nitrofurantoin use. Chest 1989; 96: 512-515.
  26. Hooper D.C. In G.L. Mandell, J.E. Bennett, and R. Dolin (eds.) / Principles and Practice of Infectious Diseases (4th ed.). New York: Churchill Livingstone, 1995. P. 376-381.
  27. Gait J.E. Hemolytic reactions to nitrofurantoin in patients with glucose-6-phosphate dehydrogenase deficiency: theory and practice. DICP 1990; 24: 1210-1213.
  28. Uhari M., Nuutinen M., Turtinen J. Turtinen Adverse reactions in children during long-term antimicrobial therapy. Pediatr Infect Dis J 1996; 15: 404-408.
  29. Zielonka T.M., Demkow U., Kus J. Pulmonary reaction after furazidin (Furagin). Case report. Pol Arch Med Wewn 1997; 97: 465-472.
  30. Crocchiolo P. Single-Dose Fosfomycin Trometamol versus Multiple-Dose Cotrimaxazole in the Treatment of Lower Urinary Tract Infections in General Practice. Chemotherapy 1990; 36: 37-40.
  31. Patel S.S., Balfour J.A., Bryson H.M. Fosfomycin Tromethamine. Drugs 1997; 53: 637-656.
  32. Blindness and neuropathy from diiodohydroxyquin-like drugs. Committee on drugs // Pediatrics.- 1974.- Vol. 54.- P. 378-379.
  33. Hutzler D., Pevny I. Allergies to 8-hydroxyquinoline derivatives. Derm Beruf Umwelt 1988; 36: 86-90.
  34. Rose F.C., Gawel M. Clioquinol neurotoxicity: An overview. Acta Neurol Scand 1978; 70 (suppl 100): 137-145.

© 2000-2009 НИИАХ СГМА Rambler's Top100 TopList Rambler's Top100